Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

NPCE

NeuroPace Inc

Surgical & Medical Instruments & Apparatus · SIC 3841CIK 1528287Held by 1 tracked managerEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$100.0M
Net Income FY2025
$(21.0M)
EPS (Basic, as reported)
$-0.66
Net Margin FY2025
-21.5%
ROE FY2025
-112.8%
Total Equity
$19.0M
Shares Out
34M
Business description

NeuroPace Inc — Surgical & Medical Instruments & Apparatus. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2020–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 41 → 100 +19.5% CAGR
Fiscal yearFY2020FY2021⚑FY2022FY2023FY2024FY2025
Revenue4145466580100
Cost of revenue(11)(12)(13)(17)(21)(23)
Gross profit303332485977
Research & development(16)(18)(22)(21)(24)(28)
Selling, general & administrative(28)(39)(51)(55)(57)—
Selling & marketing————(40)(47)
General & administrative————(17)(19)
Total operating expenses(43)(57)(73)(75)(81)(94)
Operating income(13)(24)(41)(27)(22)(16)
Interest expense(11)(7)(8)(9)(9)(7)
Interest & investment income002333
Other income (expense), net0(5)0000
Income tax expense—————0
Net income(24)(36)(47)(33)(27)(21)
EPS — basic($117.85)($2.17)($1.91)($1.27)($0.93)($0.66)
EPS — diluted($117.85)($2.17)($1.91)($1.27)($0.93)($0.66)
Shares outstanding — basic (M)01725262933
Shares outstanding — diluted (M)01725262933
  • ⚑ Weighted-average shares changed ×1.47 between FY2021 and FY2022 — likely a stock split. Per-share figures on either side are as reported and not adjusted.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.